{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:23:41Z","timestamp":1781810621356,"version":"3.54.5"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Cystic Fibrosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118325","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:03:58Z","timestamp":1761930238000},"page":"118325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis"],"prefix":"10.1016","volume":"302","author":[{"given":"Alessandra","family":"Lipani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Lo","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Barreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bivacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Span\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valeria","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Guidone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.V.","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-6594","authenticated-orcid":false,"given":"Paola","family":"Barraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118325_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.ejmech.2025.118325_bib2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejmech.2025.118325_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","article-title":"Cystic fibrosis","volume":"10","author":"Mall","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.118325_bib4","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.118325_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20212006","article-title":"Molecular mechanisms of cystic fibrosis \u2013 how mutations lead to misfunction and guide therapy","volume":"42","author":"Farinha","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2025.118325_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcf.2025.02.012","article-title":"Cystic fibrosis year in review 2024","volume":"24","author":"Alameeri","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118325_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcf.2013.12.003","article-title":"The relative frequency of CFTR mutation classes in European patients with cystic fibrosis","volume":"13","author":"De Boeck","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118325_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.med.58.071905.105316","article-title":"Airway surface dehydration in cystic fibrosis: pathogenesis and therapy","volume":"58","author":"Boucher","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib9","doi-asserted-by":"crossref","first-page":"L372","DOI":"10.1152\/ajplung.1997.272.2.L372","article-title":"Effect of anion transport inhibition on mucus secretion by airway submucosal glands","volume":"272","author":"Inglis","year":"1997","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118325_bib11","series-title":"Annual Reports","author":"Zolin","year":"2021"},{"key":"10.1016\/j.ejmech.2025.118325_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"10.1016\/j.ejmech.2025.118325_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(98)70441-X","article-title":"Comparison of the clinical manifestations of cystic fibrosis in black and white patients","volume":"132","author":"Hamosh","year":"1998","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmech.2025.118325_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","article-title":"Molecular structure of the Human CFTR ion channel","volume":"169","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118325_bib15","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1073\/pnas.1815287115","article-title":"Molecular structure of the ATP-bound, phosphorylated human CFTR","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1067\/mpd.2002.120269","article-title":"Cystic fibrosis: a 2002 update","volume":"140","author":"Orenstein","year":"2002","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmech.2025.118325_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.chembiol.2013.06.004","article-title":"Revertants, low temperature, and correctors reveal the mechanism of F508del-CFTR rescue by VX-809 and suggest multiple agents for full correction","volume":"20","author":"Farinha","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores \u0394F508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2019.07.037","article-title":"An overview on chemical structures as \u0394F508-CFTR correctors","volume":"180","author":"Span\u00f2","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112631","article-title":"Current development of CFTR potentiators in the last decade","volume":"204","author":"Span\u00f2","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2019.07.025","article-title":"Furocoumarins as multi-target agents in the treatment of cystic fibrosis","volume":"180","author":"Carbone","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib22","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1038\/s41598-023-34440-0","article-title":"Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel","volume":"13","author":"Renda","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118325_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116691","article-title":"Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis","volume":"276","author":"Barreca","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/molecules26051275","article-title":"Evaluation of fused pyrrolothiazole systems as correctors of mutant CFTR protein","volume":"26","author":"Span\u00f2","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118325_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2025.118325_bib26","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118325_bib27","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-2600(24)00411-9","article-title":"Vanzacaftor\u2013tezacaftor\u2013deutivacaftor versus elexacaftor\u2013tezacaftor\u2013ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials","volume":"13","author":"Keating","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.ade2216","article-title":"Molecular structures reveal synergistic rescue of D508 CFTR by Trikafta modulators","volume":"378","author":"Fiedorczuk","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118325_bib31","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1074\/jbc.274.6.3414","article-title":"Regulation of Cl-\/HCO3 -Exchange by cystic Fibrosis transmembrane conductance regulator expressed in NIH 3T3 and HEK 293 cells","volume":"274","author":"Lee","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.37963","article-title":"SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion","volume":"7","author":"Ahmadi","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118325_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biocel.2014.03.022","article-title":"The TMEM16A chloride channel as an alternative therapeutic target in cystic fibrosis","volume":"52","author":"Sondo","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib34","doi-asserted-by":"crossref","first-page":"L593","DOI":"10.1152\/ajplung.00321.2015","article-title":"Generation and functional characterization of epithelial cells with stable expression of SLC26A9 Cl- channels","volume":"310","author":"Salomon","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/mol.119.117143","article-title":"ORKAMBI-mediated rescue of mucociliary clearance in cystic fibrosis primary respiratory cultures is enhanced by arginine uptake, arginase inhibition, and promotion of nitric oxide signaling to the cystic fibrosis transmembrane conductance regulator channe","volume":"96","author":"Wu","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib36","doi-asserted-by":"crossref","first-page":"L12","DOI":"10.1152\/ajplung.00178.2016","article-title":"The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9","volume":"312","author":"Bertrand","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib37","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcf.2017.10.006","article-title":"Ion channels as targets to treat cystic fibrosis lung disease","volume":"17","author":"Martin","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118325_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1183\/09031936.03.00098803","article-title":"Innate immunity in the lung: how epithelial cells fight against respiratory pathogens","volume":"23","author":"Bals","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.118325_bib39","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1042\/BST20170402","article-title":"Mucins: the frontline defence of the lung","volume":"46","author":"Ridley","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2025.118325_bib40","doi-asserted-by":"crossref","first-page":"18703","DOI":"10.1073\/pnas.1422091112","article-title":"pH modulates the activity and synergism of the airway surface liquid antimicrobials \u03b2-defensin-3 and LL-37","volume":"111","author":"Abou Alaiwa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118325_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib43","doi-asserted-by":"crossref","first-page":"15973","DOI":"10.1073\/pnas.1311999110","article-title":"Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways","volume":"110","author":"Garland","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jcf.2017.06.005","article-title":"Bicarbonate in cystic fibrosis","volume":"16","author":"Kunzelmann","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2025.118325_bib45","doi-asserted-by":"crossref","first-page":"L415","DOI":"10.1152\/ajplung.00010.2024","article-title":"Mucociliary clearance is impaired in small airways of cystic fibrosis pigs","volume":"327","author":"Stewart","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/164_2023_698","article-title":"SLC26 anion transporters","volume":"283","author":"Geertsma","year":"2024","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib47","first-page":"1","article-title":"Chloride\/multiple anion exchanger SLC26A family: systemic roles of SLC26A4 in various organs","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118325_bib48","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.4049\/jimmunol.178.8.5144","article-title":"Thiocyanate transport in resting and IL-4-Stimulated human bronchial epithelial cells: role of pendrin and anion channels","volume":"178","author":"Pedemonte","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2025.118325_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/srep36016","article-title":"Goblet cell hyperplasia requires high bicarbonate transport to support mucin release","volume":"6","author":"Gorrieri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118325_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164944","article-title":"Airway surface hyperviscosity and defective mucociliary transport by IL-17\/TNF-\u03b1 are corrected by \u03b2-adrenergic stimulus","volume":"7","author":"Guidone","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2025.118325_bib51","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1165\/rcmb.2018-0158OC","article-title":"Pendrin mediates bicarbonate secretion and enhances cystic fibrosis transmembrane conductance regulator function in airway surface epithelia","volume":"60","author":"Kim","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib52","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1096\/fj.201600223R","article-title":"Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis","volume":"30","author":"Haggie","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.118325_bib53","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.7150\/thno.46417","article-title":"Inhibition of pendrin by a small molecule reduces lipopolysaccharide-induced acute Lung Injury","volume":"10","author":"Lee","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2025.118325_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000149780","article-title":"Characterization of SLC26A9, facilitation of Cl(-) transport by bicarbonate","volume":"22","author":"Loriol","year":"2008","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib55","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fphar.2018.01112","article-title":"Role of the SLC26A9 chloride channel as disease modifier and potential therapeutic target in cystic fibrosis","volume":"9","author":"Bal\u00e1zs","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200810097","article-title":"SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia","volume":"133","author":"Bertrand","year":"2009","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib57","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1172\/JCI60429","article-title":"SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation","volume":"122","author":"Anagnostopoulou","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118325_bib58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1126\/science.1163518","article-title":"TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity","volume":"322","author":"Caputo","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.ejmech.2025.118325_bib59","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.09.003","article-title":"Expression cloning of TMEM16A as a calcium-activated chloride channel subunit","volume":"134","author":"Schroeder","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118325_bib60","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nature07313","article-title":"TMEM16A confers receptor-activated calcium-dependent chloride conductance","volume":"455","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118325_bib61","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128414","article-title":"Niclosamide repurposed for the treatment of inflammatory airway disease","volume":"4","author":"Cabrita","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2025.118325_bib62","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1164\/rccm.201908-1641OC","article-title":"TMEM16A potentiation: a novel therapeutic approach for the treatment of cystic fibrosis","volume":"201","author":"Danahay","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib63","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1210\/endo.141.2.7303","article-title":"Pendrin, the protein encoded by the pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells","volume":"141","author":"Royaux","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2025.118325_bib64","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1038\/s41467-023-38303-0","article-title":"Asymmetric pendrin homodimer reveals its molecular mechanism as anion exchanger","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118325_bib65","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41467-023-44612-1","article-title":"Mechanism of anion exchange and small-molecule inhibition of pendrin","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118325_bib66","doi-asserted-by":"crossref","first-page":"41069","DOI":"10.1074\/jbc.M111.266734","article-title":"Novel role for pendrin in orchestrating bicarbonate secretion in cystic fibrosis transmembrane conductance regulator (CFTR)-expressing airway serous cells","volume":"286","author":"Garnett","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib67","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00424-003-1090-3","article-title":"The SLC26 gene family of multifunctional anion exchangers","volume":"447","author":"Mount","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejmech.2025.118325_bib68","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1159\/000445559","article-title":"Effect of known inhibitors of ion transport on pendrin (SLC26A4) activity in a human kidney cell line","volume":"38","author":"Bernardinelli","year":"2016","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib69","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1681\/ASN.2015121312","article-title":"Small-molecule inhibitors of pendrin potentiate the diuretic action of furosemide","volume":"27","author":"Cil","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2025.118325_bib70","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.bmcl.2019.07.003","article-title":"Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin)","volume":"29","author":"Zhu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118325_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117133","article-title":"High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diuretics","volume":"283","author":"Master","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib72","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2019.07.016","article-title":"Novel pendrin inhibitor attenuates airway hyperresponsiveness and mucin expression in experimental murine asthma","volume":"144","author":"Park","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejmech.2025.118325_bib73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00232-009-9165-5","article-title":"Slc26a9--anion exchanger, channel and Na+ transporter","volume":"228","author":"Chang","year":"2009","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib74","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1074\/jbc.M111802200","article-title":"Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9","volume":"277","author":"Lohi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib75","doi-asserted-by":"crossref","first-page":"17955","DOI":"10.1073\/pnas.0800616105","article-title":"Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach","volume":"105","author":"Xu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib76","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46986","article-title":"Cryo-EM structures and functional characterization of murine Slc26a9 reveal mechanism of uncoupled chloride transport","volume":"8","author":"Walter","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118325_bib77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41421-020-00193-7","article-title":"Structural insights into the gating mechanism of human SLC26A9 mediated by its C-terminal sequence","volume":"6","author":"Chi","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejmech.2025.118325_bib78","series-title":"Elevator Motion of Chloride Ion Transporter SLC26A9 Induced by STAS Domain","first-page":"1","author":"Omori","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118325_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313064","article-title":"Synergy in cystic fibrosis therapies: targeting SLC26A9","volume":"22","author":"Pinto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118325_bib80","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/biom12020202","article-title":"SLC26A9 as a potential modifier and therapeutic target in cystic fibrosis lung disease","volume":"12","author":"Gorrieri","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.118325_bib81","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcf.2015.06.002","article-title":"Targeting ion channels in cystic fibrosis","volume":"14","author":"Mall","year":"2015","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"10.1016\/j.ejmech.2025.118325_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41525-022-00299-9","article-title":"Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease","volume":"7","author":"Gong","year":"2022","journal-title":"NPJ Genomic Med."},{"key":"10.1016\/j.ejmech.2025.118325_bib83","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1113\/jphysiol.2007.135855","article-title":"SLC26A9 is a Cl(-) channel regulated by the WNK kinases","volume":"584","author":"Dorwart","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib84","doi-asserted-by":"crossref","first-page":"L1147","DOI":"10.1152\/ajplung.00563.2020","article-title":"Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia","volume":"321","author":"Larsen","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib85","article-title":"The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion","volume":"36","author":"Jo","year":"2022","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib86","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.bpj.2009.09.024","article-title":"The TMEM16 protein family: a new class of chloride channels?","volume":"97","author":"Galietta","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2025.118325_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature25024","article-title":"Cryo-EM structures of the TMEM16A calcium-activated chloride channel","volume":"552","author":"Dang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118325_bib88","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39122","article-title":"Calcium-dependent electrostatic control of anion access to the pore of the calcium-activated chloride channel TMEM16A","volume":"7","author":"Lam","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118325_bib89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature24652","article-title":"Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM","volume":"552","author":"Paulino","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118325_bib90","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1073\/pnas.1703391114","article-title":"Characterization of the scrambling domain of the TMEM16 family","volume":"114","author":"Gyobu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib91","doi-asserted-by":"crossref","first-page":"13305","DOI":"10.1074\/jbc.M113.457937","article-title":"Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members","volume":"288","author":"Suzuki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib92","doi-asserted-by":"crossref","first-page":"21413","DOI":"10.1073\/pnas.0911935106","article-title":"Studies on expression and function of the TMEM16A calcium-activated chloride channel","volume":"106","author":"Huang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib93","doi-asserted-by":"crossref","first-page":"16354","DOI":"10.1073\/pnas.1214596109","article-title":"Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118325_bib94","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nn.3111","article-title":"The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons","volume":"15","author":"Cho","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118325_bib95","doi-asserted-by":"crossref","first-page":"28698","DOI":"10.1074\/jbc.M109.012120","article-title":"Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport","volume":"284","author":"Ousingsawat","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib96","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1074\/jbc.C109.000869","article-title":"Transmembrane protein 16A (TMEM16A) is a Ca2+-regulated Cl- secretory channel in mouse airways","volume":"284","author":"Rock","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib97","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1113\/jphysiol.2012.240838","article-title":"Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia","volume":"590","author":"Scudieri","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib98","first-page":"4502","article-title":"TMEM16A is indispensable for basal mucus secretion in airways and intestine","volume":"33","author":"Benedetto","year":"2019","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejmech.2025.118325_bib99","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/bph.15995","article-title":"Analysis of inhibitors of the anoctamin-1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium signalling","volume":"180","author":"Genovese","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1142342","article-title":"Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A","volume":"14","author":"Danahay","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib101","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1096\/fj.11-191627","article-title":"Small\u2010molecule activators of TMEM16A, a calcium\u2010activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction","volume":"25","author":"Namkung","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.118325_bib102","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1113\/JP278784","article-title":"TRPV4 and purinergic receptor signalling pathways are separately linked in airway epithelia to CFTR and TMEM16A chloride channels","volume":"597","author":"Genovese","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2025.118325_bib103","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1096\/fba.2020-00035","article-title":"Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction","volume":"2","author":"Danahay","year":"2020","journal-title":"FASEB BioAdvances"},{"key":"10.1016\/j.ejmech.2025.118325_bib104","unstructured":"https:\/\/assets.roche.com\/f\/176343\/x\/a460ba236d\/pharmahy25.pdf."},{"key":"10.1016\/j.ejmech.2025.118325_bib105","series-title":"Benzimidazole Derivatives for Treating Respiratory Disease","author":"Collingwood","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118325_bib106","series-title":"Compounds for Treating Respiratory Disease","author":"Collingwood","year":"2020"},{"key":"10.1016\/j.ejmech.2025.118325_bib107","series-title":"Preparation of Aminobenzamides, Aminopyridinecarboxamides and Aminopyrimidinecarboxamides as calcium-activated Chloride Channel TMEM16A Modulators for the Treatment of Diseases, Particularly Respiratory Diseases and Conditions","author":"Collingwood","year":"2019"},{"key":"10.1016\/j.ejmech.2025.118325_bib108","series-title":"Pyridine Derivatives as calcium-activated Chloride Channel Modulators","author":"Collingwood","year":"2021"},{"key":"10.1016\/j.ejmech.2025.118325_bib109","series-title":"Solid Forms of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-N-(1,1-dimethylprop-2-ynyl)pyridine-2-carboxamide, WO2021014168","author":"Maas","year":"2021"},{"key":"10.1016\/j.ejmech.2025.118325_bib110","series-title":"Modulators of TMEM16A for Treating Respiratory Disease","author":"Collingwood","year":"2020"},{"key":"10.1016\/j.ejmech.2025.118325_bib111","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/bph.17383","article-title":"Pharmacological profiling of small molecule modulators of the TMEM16A channel and their implications for the control of artery and capillary function","volume":"182","author":"Al-Hosni","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib112","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/mol.107.043208","article-title":"Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel","volume":"73","author":"De La Fuente","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib113","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1074\/jbc.M110.175109","article-title":"TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells","volume":"286","author":"Namkung","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib114","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3109\/14756366.2015.1135912","article-title":"Synthesis and evaluation of 5,6-disubstituted thiopyrimidine aryl aminothiazoles as inhibitors of the calcium-activated chloride channel TMEM16A\/Ano1","volume":"31","author":"Piechowicz","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib115","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.bmc.2012.05.074","article-title":"Novel 5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium activated chloride channel inhibitors","volume":"20","author":"Kumar","year":"2012","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib116","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/mol.113.087502","article-title":"Monna, a potent and selective blocker for transmembrane protein with unknown function 16\/anoctamin-1","volume":"84","author":"Oh","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118325_bib117","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-6606-1-14","article-title":"Development of selective blockers for Ca2(+)-activated Cl channel using Xenopus laevis oocytes with an improved drug screening strategy","volume":"1","author":"Oh","year":"2008","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejmech.2025.118325_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0155771","article-title":"Ani9, a novel potent small-molecule ANO1 inhibitor with negligible effect on ANO2","volume":"11","author":"Seo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118325_bib119","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmech.2018.10.002","article-title":"Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors","volume":"160","author":"Seo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118325_bib120","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1021\/acs.jmedchem.7b00020","article-title":"Substituted 2-Acylaminocycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of the calcium-activated chloride channel transmembrane protein 16A (TMEM16A)","volume":"60","author":"Truong","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:01:38Z","timestamp":1780909298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":120,"alternative-id":["S0223523425010906"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118325","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118325"}}